AbbVie and BridgeBio have emerged as leaders in the BioSpace 2026 Best Places to Work list, as determined by feedback from over 7,600 life sciences professionals. Based in North Chicago, AbbVie ranks as the top large employer, while Palo Alto’s BridgeBio takes the lead among small employers.

The Best Places to Work list showcases 50 companies operating in the U.S., comprising 20 large and 30 small employers. Nominations were accepted in June, followed by voting from life sciences professionals in August. Following AbbVie in the large employers category are Eli Lilly and Company, Insmed, Amneal Pharmaceuticals, and Vertex Pharmaceuticals. In the small employers category, BridgeBio is accompanied by Tarsus Pharmaceuticals, Mediar Therapeutics, Avidity Biosciences, and EyePoint.

According to Josh Goodwin, CEO of BioSpace, “Best Places to Work winners set the standard for what makes a great workplace.” He emphasizes that these organizations excel through a combination of factors, including career growth opportunities, innovation, and effective leadership, which are essential for attracting and retaining top life sciences talent.

Voters evaluated their top three preferred workplaces and rated companies based on eight crucial attributes: compensation, innovation, career growth opportunities, leadership, culture, diversity, equity and inclusion (DEI), reputation, and flexibility around remote work options.

Chris Tse, site head and vice president of discovery research and early development at AbbVie, expressed gratitude for the recognition. He described AbbVie’s culture as patient-centered, emphasizing the collective commitment to tackling challenging scientific issues with determination and rigor. Tse highlighted the value of collaboration, stating, “Fostering a cooperative environment rooted in empathy, respect, and growth makes AbbVie’s culture truly exceptional.”

Amneal Pharmaceuticals: Creating Opportunities for Impact

Making its debut on the BioSpace Best Places to Work list, Amneal Pharmaceuticals, located in Bridgewater, New Jersey, secured the fourth spot. The pharmaceutical company, known for developing and distributing over 280 drugs, received high ratings across all evaluated attributes, particularly for its reputation, culture, and DEI initiatives. Nikita Shah, executive vice president and chief human resources officer, attributed this recognition to Amneal’s commitment to cultivating a workplace where employees feel valued and can see the impact of their work on patients’ lives.

Shah stated, “Our shared purpose of ‘making healthy possible’ influences our culture.” She emphasized the company’s initiatives such as Amneal Listens and MyAmneal Career, which empower employees and provide clear development pathways. “What makes Amneal special is our entrepreneurial spirit, strong leadership, and the belief that great ideas can originate from anyone,” she added.

BridgeBio: Empowering Employees Through Minimalism

BridgeBio, which excels in discovering and delivering treatments for genetic diseases, also scored well across all eight attributes. Josh Loehrer, chief people officer, noted that the company’s success stems from its focus on small, high-performing teams and a streamlined environment that minimizes bureaucracy. “We create a setting where employees can do their best work,” he explained, underlining the importance of giving those closest to the issues a say in decision-making.

Although BridgeBio does not have a flat organizational structure, it operates in a decentralized manner, encouraging open communication. “We aim for those who understand the intricacies to drive our decision-making,” Loehrer added. The company prioritizes a quality process alongside outcomes to foster success over time.

Looking Ahead: The Future of Workplaces in Life Sciences

As both AbbVie and BridgeBio continue to grow, they remain committed to enhancing their workplace cultures and employee engagement. AbbVie plans to focus on collaboration and patient-centric initiatives, while BridgeBio is set to refine its onboarding experience and foster community connections among employees.

The winners of the 2026 Best Places to Work for large employers include: AbbVie, Eli Lilly and Company, Insmed, Amneal Pharmaceuticals, and Vertex Pharmaceuticals. Meanwhile, the small employers’ rankings feature: BridgeBio, Tarsus Pharmaceuticals, Mediar Therapeutics, Avidity Biosciences, and EyePoint Pharmaceuticals.

For further insights, visit the detailed 2026 Best Places to Work page.

Top Employers in the Life Sciences Industry of 2026

In 2026, two standout companies have been recognized as the best places to work in the life sciences sector. These companies—AbbVie and BridgeBio—have emerged as leaders in creating exceptional workplace environments, driven by employee satisfaction and a commitment to innovation.

Highlights from the Awards

The prestigious acknowledgment comes from a survey involving over 7,600 professionals in the life sciences field. AbbVie, based in North Chicago, took the top spot among large employers, while Palo Alto’s BridgeBio was recognized for its small employer category. This list features 50 companies with notable U.S. operations, as life sciences experts cast their votes based on nominations made earlier in the year.

Criteria for Evaluation

Nominees were assessed across various factors that contribute to a fulfilling workplace. Key attributes include compensation, innovation, career growth opportunities, leadership effectiveness, company culture, diversity, equity, inclusion (DEI), reputation, and flexibility in working arrangements. These criteria collectively ensure that employees find value in their roles while contributing meaningfully to patient care.

AbbVie’s Commitment to Excellence

As the leader in the large employer category, AbbVie celebrates a culture focused on patient welfare and collaboration. Chris Tse, the site head at AbbVie, articulated that the recognition validates the company’s commitment to science and its employees. With an emphasis on teamwork and respect, AbbVie strives to nurture an environment where each individual’s contribution is recognized and valued.

BridgeBio’s Innovative Work Culture

BridgeBio, renowned for its focus on genetic therapies, champions a distinctive approach that prioritizes flexibility and innovation. Josh Loehrer, the company’s chief people officer, conveyed that their success stems from creating teams of high-performing individuals while minimizing bureaucratic hurdles. This strategy allows employees to thrive and contribute effectively to the company’s mission of patient-focused innovation.

Insights from Amneal Pharmaceuticals

Amneal Pharmaceuticals made a remarkable entry, securing the fourth spot amongst small employers. The company’s strong reputation and commitment to a collaborative culture are key factors that contribute to its workplace excellence. Nikita Shah, the executive vice president of human resources, emphasized the importance of fostering an environment where employees feel heard and valued, encouraging growth and innovation at all levels.

Future Directions for Growth

Both AbbVie and BridgeBio are continually evolving their workplace strategies to optimize employee engagement and career development. Initiatives like enhanced talent development programs and community impact efforts are at the forefront of their growth plans. These strategies not only aim to improve organizational performance but also enhance employee satisfaction and retention.

Conclusion: The Future of Work in Life Sciences

The accolades bestowed upon these innovative companies highlight the essential role of workplace culture in the life sciences sector. By prioritizing employee satisfaction and actively engaging in community support, AbbVie and BridgeBio set a high standard for others in the industry. As the sector evolves, the commitment to a supportive, engaging work environment will remain vital for attracting and retaining top talent.